HOPO THERAPEUTICS, INC.
BERKELEY, CALIFORNIA 947041717
$9.37M
Total Contract Value
2 awards
First Award
Sep 27, 2024
Last Award
Nov 5, 2025
Business Size
other than small
CAGE Code
8L3L6
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $9.37M | 2 |
Contract Awards
1 awards found
75A50124C00062
Department of Health and Human Services
$9.37M
Sep 27, 2024
DEVELOPMENT OF HOPO-101 AS AN MCM (MEDICAL COUNTERMEASURE) DECORPORATION AGENT FOR THE TREATMENT OF INDIVIDUALS WITH KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH RADIONUCLIDES (THE ?MCM INDICATION?) AND/OR TOXIC HEAVY METALS OF INTEREST FOR COMMERC
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
Business Details
- UEI
- H5MWN5ZBXQ98
- CAGE Code
- 8L3L6
- Address
- 2630 BANCROFT WAY
BERKELEY, CA 947041717 - Congressional District
- CA-12
- Phone
- 5102393180
Parent Company
HOPO THERAPEUTICS, INC.
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov